Delivery Order SPE2DB24D2010-SPE2DB25FAAEZ
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $9,611.30. The contract is a firm fixed price, non-set-aside award with a period of performance through May 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products, with a ceiling value of $5,112.59 and a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.27 firm fixed-price contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a performance period through January 16, 2025 and was awarded on January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $14,659.35 and a period of performance through April 28, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $5,678.20. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,687.32, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. The contract has a period of performance through February 13, 2025 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $6,938.75. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,038.50. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. It is a firm fixed price contract with a period of performance through June 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,287.74 and a completion date of June 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,313.21, is for the supply of 4567957182 ! ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a firm fixed-price, non-set-aside award with a performance period through April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAEZDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $5,746.38 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/7/25 |